APA (7th ed.) Citation

P, V., M, V., S, F., J, S., M, M., U, M., & A, D. (2025). Development of a novel physiologically based biopharmaceutics modeling (PBBM) framework using the open systems pharmacology suite, part 2: In vivo pharmacokinetic modeling of vericiguat. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 212, 107189. https://doi.org/10.1016/j.ejps.2025.107189

Chicago Style (17th ed.) Citation

P, Vrenken, Vertzoni M, Frechen S, Solodenko J, Meyer M, Muenster U, and Dallmann A. "Development of a Novel Physiologically Based Biopharmaceutics Modeling (PBBM) Framework Using the Open Systems Pharmacology Suite, Part 2: In Vivo Pharmacokinetic Modeling of Vericiguat." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences 212 (2025): 107189. https://doi.org/10.1016/j.ejps.2025.107189.

MLA (9th ed.) Citation

P, Vrenken, et al. "Development of a Novel Physiologically Based Biopharmaceutics Modeling (PBBM) Framework Using the Open Systems Pharmacology Suite, Part 2: In Vivo Pharmacokinetic Modeling of Vericiguat." European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences, vol. 212, 2025, p. 107189, https://doi.org/10.1016/j.ejps.2025.107189.